23 completed, 15 recruiting, 5 unknown, 3 not yet recruiting. 19 Not applicable, 10 Phase 2, 4 Phase 1, 4 Phase 3, 2 Phase 4.
Follow DEXA: new trials by email Literature Review of DEXA trials Research Report on DEXA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial Androgen Receptor Pathway Inhibitor, Transdermal Estrogen, Bone Scan - Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 60 | 2026-11-01 | 2026-10-16 |
| Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors Biospecimen Collection, Dual X-ray Absorptiometry, Functional Assessment - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 4 | Not yet recruiting | Mayo Clinic | 50 | 2026-09-01 | 2026-08-17 |
| Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance VO2 Max, DEXA, Peripheral Microvascular Reactivity - Insulin Resistance | Recruiting | AdventHealth Translational Research Institute | 36 | 2026-06-11 | 2026-08-12 | |
| Modified DHAP Versus Standard DHAP in Relapsed/Refractory Diffused Large B-cell Lymphoma. Cisplatin (modified schedule), Cisplatin, Dexametasone - DLBCL - Diffuse Large B Cell Lymphoma | Phase 3 | Recruiting | King Edward Medical University | 74 | 2026-03-18 | 2026-08-10 |
| Comparison of Bone Microarchitecture Analysed by HRpQCT and pQCT in Pathologies With Bone Loss and/or Muscle Loss HR-pQCT, pQCT, DEXA - Osteoporosis Risk, Bone Loss | Not applicable | Recruiting | Centre Hospitalier Universitaire de Saint Etienne | 1000 | 2026-02-02 | 2026-03-03 |
| Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial Aerobic Exercise, Exercise Intervention, Educational Intervention - Lung Non-Small Cell Carcinoma | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 100 | 2026-01-28 | 2026-06-23 |
| Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis Magnetic Resonance Liver Assessment, Bike Exercise VO2max, DEXA - Type 2 Diabetes, Hepatic Steatosis | Not applicable | Recruiting | AdventHealth Translational Research Institute | 12 | 2025-04-25 | 2026-08-12 |
| A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults Neuromuscular Test, DEXA, Mixed Meal Tolerance Test - Healthy, Insulin Resistance | Recruiting | Mayo Clinic | 80 | 2025-02-26 | 2026-08-05 | |
| Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) Ruxolitinib, Etoposide, Dexamethasone - Hemophagocytic Lymphohistiocytoses | Phase 2 | Recruiting | Jerry Lee, MD, MSc, MPhil | 54 | 2024-10-01 | 2026-09-21 |
| Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study Biopsy Procedure, Biospecimen Collection, Bone Scan - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 2 | Recruiting | University of Washington | 69 | 2024-05-21 | 2026-07-21 |
| Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research (VAL) endothelial cell collection - Obesity | Recruiting | Bettina Mittendorfer | 100 | 2024-05-08 | 2026-08-04 | |
| Vitamin D for Prostate Endocrine Therapy Biospecimen Collection, D Vitamin, Dual X-ray Absorptiometry - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 | Phase 3 | Recruiting | University of Rochester | 240 | 2023-12-14 | 2026-01-15 |
| Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer Biospecimen Collection, Bone Scan, Brachytherapy - Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 | Phase 2 | Not yet recruiting | University of Kansas Medical Center | 90 | 2023-11-20 | 2023-11-13 |
| Exercise Response in Humans With Obesity Treadmill Test, Strength Test, Dual-Energy X-Ray Absorptiometry - Obese | Recruiting | Mayo Clinic | 120 | 2023-09-22 | 2026-09-11 | |
| Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients Low Intensity Vibration Therapy, Dual X-ray Absorptiometry, Biospecimen Collection - Hematopoietic and Lymphoid System Neoplasm | Not applicable | Recruiting | Roswell Park Cancer Institute | 75 | 2023-08-14 | 2026-08-21 |
| The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients Biospecimen Collection, Cardiopulmonary Exercise Testing, Dual X-ray Absorptiometry - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent Non-hodgkin Lymphoma | Not applicable | Recruiting | Mayo Clinic | 70 | 2023-06-12 | 2026-04-09 |
| OsteoPorosis Treatment Identification Using Machine Learning Dual Energy Xray Absorptiometry - Osteoporosis Risk, Osteoporosis | Unknown | NHS Greater Glasgow and Clyde | 250 | 2023-02-01 | 2023-01-10 | |
| Menier's Disease - Bone Density Study vitamin D plasma levels baseline, Dual-energy X-ray absorptiometry at baseline, cervical Vestibular evoked myogenic potentials at baseline - Meniere Disease, Osteoporosis | Not applicable | Not yet recruiting | HaEmek Medical Center, Israel | 60 | 2022-10-01 | 2022-08-03 |
| Digital Twin - Modelling Postprandial Triglyceride and Glucose Responses Mixed meal challenge test, MRI, DEXA - Lipid Metabolism, Glucose Metabolism | Completed | Wageningen University and Research | 38 | 2022-03-28 | 2022-07-06 | |
| Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint - Colorectal Carcinoma, Endometrial Carcinoma | Phase 1 / Phase 2 | Recruiting | Children's Oncology Group | 147 | 2021-11-08 | 2026-08-25 |
Showing 20 of 51. Sign in to see all of them.
Osteoporosis (8) · Prostatic Neoplasms (6) · Bone Diseases, Metabolic (4) · Insulin Resistance (4) · Anorexia Nervosa (3) · Obesity (3) · Fatty Liver (2) · Lymphoma, Non-Hodgkin (2) · Multiple Myeloma (2) · Vitamin D Deficiency (2) · Acquired Immunodeficiency Syndrome (1) · Acro-Osteolysis (1) · Agnosia (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1)
Mayo Clinic (7) · Centre Hospitalier Universitaire de Saint Etienne (4) · AdventHealth Translational Research Institute (3) · Fred Hutchinson Cancer Center (3) · M.D. Anderson Cancer Center (2) · National Cancer Institute (NCI) (2) · AEterna Zentaris (1) · Adana Numune Training and Research Hospital (1) · Asan Medical Center (1) · Bettina Mittendorfer (1) · Children's Oncology Group (1) · Cooperative Study Group A for Hematology (1) · Dow University of Health Sciences (1) · HaEmek Medical Center, Israel (1) · Jerry Lee, MD, MSc, MPhil (1)
United States (30) · France (6) · Denmark (2) · Netherlands (2) · Pakistan (2) · South Korea (2) · United Kingdom (2) · Canada (1) · Israel (1)
Alain Mina, M.D. (1) · Amanda Lynggaard Riis, Student (1) · Arfa Baig, FCPS (1) · Bettina Mittendorfer, PhD (1) · Brian Focht, PhD, FACSM (1) · Cassie Kennedy, MD (1) · Diederik J Esser, PhD (1) · Dimana Dimitrova, M.D. (1) · Dong-Woo Kang, PhD (1) · Ejigayehu G Abate, M.D (1) · Ellen-Margrethe Hauge, Professor (1) · Frances J Hayes, MD (1) · Frederik Cosedis Enevoldsen, Student (1) · Giada Sebastiani (1)
PMID 21990396, PMID 22804876, PMID 25429526, PMID 29398518, PMID 36853719, PMID 38340159, PMID 40331908, PMID 40460271
2015 (1), 2019 (1), K23HL128859 (1), K23HL183845 (1), K99DK135915 (1), P30CA168524 (1), P50CA097186 (1), R00CA287050 (1), R01AG062859 (1), R01CA258349 (1), UG1CA189961 (1), UM1CA228823 (1)